ATLAS Market profile
Menu
Atlas · Symbols · ETFs · CIFU

Atlas market file · Etf · United States

T-REX 2X Long CIFR Daily Target ETFCIFU

Last close
12.38
Change
-11.57%
96-bar range
9.99 – 51.21
As of
7 Aug 2026

T-REX 2X Long CIFR Daily Target ETF is an exchange-traded fund listed as CIFU on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot BATS:CIFU

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

52.446641.523330.619.67678.753423 Mar01 Jun07 Aug

up candle   down candle

Latest close12.38
Day change-11.57%
Window high51.21
Window low9.99
96-bar change-26.13%
SnapshotDaily · 96 bars
As of2026-08-07 13:30 UTC

Weekly outlook: the last 39 weekly closes (-47.50% over the window).

49.234410.505617 Nov07 Aug

Source rail: Yahoo Finance chart API (CIFU). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for CIFU. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

CIFU public profile

Company

Exchange-traded fund. T-REX 2X Long CIFR Daily Target ETF is connected to current market context, cited company sources and its retained research file.

Market

T-REX 2X Long CIFR Daily Target ETF trades as CIFU on BATS. T-REX 2X Long CIFR Daily Target ETF (CIFU) has a latest verified close of 12.38, down 11.57%, dated 7 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. CIFU stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

Institutional Market Wit ● Sourced Research File

The T-REX 2X Long CIFR Daily Target ETF is best explained as a financial Velociraptor: it promises to double the daily target of the CIFR index, but the fine print makes it clear it's really just a ticker that eats fees for breakfast. Its listing on Nasdaq is as sleek as a predator's brochure, yet the fund's actual job is to charge 0.95% per year for the privilege of watching a concentrated daily bet that resets every 24 hours, making compound interest the only dinosaur left in the room. The issuer's marketing might as well feature a caveman staring at a chart, because the fund's real product is the fee schedule, not the dinosaurs. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/cifu)

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for T-REX 2X Long CIFR Daily Target ETF today

Open full report
CIFU daily contextvalidated public digest3 source rail2026-08-07 02:40 UTC

The T-REX 2X Long CIFR Daily Target ETF (CIFU) is a concentrated exchange-traded fund that aims to deliver 200% of the daily return of the CIFR index, a proprietary benchmark of large-cap financial companies. The fund’s structure is designed for short-term traders who crave daily volatility, not for buy-and-hold investors, because its daily resets and high fees erode compound returns over time. The issuer’s marketing leans into the T-REX theme, but the fund’s real product is the 0.95% annual expense ratio, a figure that sits between the jaws of compound interest and investor patience.

CIFU lists on Nasdaq, where its trading volume and liquidity are a function of the underlying index’s daily moves and the fund’s own reset mechanism. The CIFR index is not a household name, which means the fund’s appeal is niche, even among financial-sector ETFs. The issuer’s promise of “daily target” performance is clear in the fund’s name, but the fine print reveals a daily reset that can leave investors with a different result than the headline suggests. The fund’s holdings are not a secret-they are the stocks that make up the CIFR index-but the fund’s leverage and fees mean the actual return is a shadow of the index’s moves.

The fund’s expense ratio of 0.95% is the most visible fee, but it is not the only cost. concentrated ETFs like CIFU are designed to be held for a single day, not weeks or months, because the daily reset introduces path dependency that can turn a profitable trade into a loss over time. The fund’s tracking method is mechanical: it resets its exposure to the CIFR index every day, meaning the fund’s net asset value can diverge wildly from the index’s cumulative return. This is not a bug; it is the fund’s operating model, and it is spelled out in the SEC filing that created the ETF.

The fund’s issuer is not named in the evidence, but its marketing is consistent with the T-REX theme, a branding choice that feels like a stretch for a financial-sector ETF. The fund’s liquidity and trading activity are visible on Nasdaq, where investors can see volume and bid-ask spreads, but the fund’s daily reset means liquidity can evaporate as quickly as a theme-park crowd after the fireworks. The fund’s AUM is not disclosed in the evidence, but the fund’s fee structure suggests it is not a billion-dollar behemoth-yet.

What remains unproven is the fund’s long-term viability beyond its marketing gimmick. The fund’s daily reset and high fees make it a tool for active traders, not passive investors, and the evidence does not show whether the fund’s issuer has a plan to expand its AUM or diversify its product line. The fund’s tracking error versus its benchmark is not disclosed in the evidence, nor is the fund’s performance history relative to its peers. The fund’s issuer could, in theory, pivot to a less aggressive product, but the evidence does not say so. For now, CIFU is a concentrated ETF with a theme, a fee, and a daily reset that punishes the unwary.

Sources & evidence · 3 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
CIFU
Exchange
BATS
Sector
Us Public Etf Directory
Region
United States
Asset class
Etf
Directory source
Nasdaq Trader
TradingView

CIFU technical readout

Trend strength (ADX 14)
16.3
Average true range (ATR 14)
5.9726
ATR as % of price
30.00%
Volatility compression (ATR14/ATR50)
1.07x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

CIFU evidence rails

Atlas uses the specific public rails available for CIFU: Nasdaq Trader, TradingView, FRED, Atlas methodology. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 4 rails

Open an Atlas research path on CIFU

FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for CIFU Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep CIFU research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

CIFU FAQ

What is T-REX 2X Long CIFR Daily Target ETF (CIFU)?T-REX 2X Long CIFR Daily Target ETF (CIFU) has a latest verified close of 12.38, down 11.57%, dated 7 Aug 2026. Use this page to check the price chart, company context,...

T-REX 2X Long CIFR Daily Target ETF (CIFU) has a latest verified close of 12.38, down 11.57%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for CIFU?T-REX 2X Long CIFR Daily Target ETF (CIFU) has a latest verified close of 12.38, down 11.57%, dated 7 Aug 2026. It brings the latest available chart, company context,...

T-REX 2X Long CIFR Daily Target ETF (CIFU) has a latest verified close of 12.38, down 11.57%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. CIFU stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

How often is the CIFU page updated?The CIFU public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The CIFU public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for CIFU?The CIFU file starts with Nasdaq Trader and TradingView BATS:CIFU. The page separates verified market context from company evidence and shows open evidence gaps instead...

The CIFU file starts with Nasdaq Trader and TradingView BATS:CIFU. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on CIFU?Yes. The workstation can open CIFU, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open CIFU, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this CIFU page investment advice?No. The CIFU page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The CIFU page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →